MDMA Moves from Party Drug Back to Therapy Tool

MDMA Moves from Party Drug Back to Therapy To...

Up next

Nobel winners, neutrino detectors and nature’s longest-living tortoise

This week’s science news roundup unpacks the 2026 Nobel Prizes—from controlling brain cells with flashes of light to catching ghostly neutrinos from distant galaxies in Antarctic ice to building mirror-image molecules one at a time. Plus, we meet Jonathan, a 194-year-old tortoise ...  Show more

The doctor fighting for pain-free IUDs

In this episode of Science Quickly, Rachel Feltman speaks with Helena Kopp Kallner, an ob-gyn and a professor, about her promising new study that shows local anesthetic can reduce pain during placements of intrauterine devices (IUDs). These devices are one of the most effective a ...  Show more

Recommended Episodes

MDMA Moves from Party Drug Back to Therapy Tool
Science Quickly

The party drug MDMA could soon be approved for treating people with severe PTSD. Learn more about your ad choices. Visit megaphone.fm/adchoices 

Ecstasy therapy
Unexplainable

The FDA is about to announce whether it’s going to approve MDMA as a treatment for PTSD. Our friends at Today, Explained explore what this kind of therapy looks like, and why it’s so controversial. For show transcripts, go to vox.com/unxtranscripts For more, go to vox.com/unexpla ...  Show more

MDMA: Pharmacological Healer
Stuff To Blow Your Mind

In the form of recreational ecstasy, the psychoactive drug MDMA carries with it a stigma of wide-eyed ravers, free love and counterculture pharmacological spirituality. But beyond its cultural legacy, MDMA offers a potent therapeutic tool for doctors and therapists -- if we ca ...

  Show more

The therapeutic potential of MDMA
The Gray Area with Sean Illing

In the ‘80s and ‘90s, MDMA (also known as molly or ecstasy) was dismissed as a club drug and became the target of anti-drug propaganda. Today, it’s on the brink of being legalized for use in clinical therapy to treat conditions like PTSD. How did that happen? And what have we lea ...  Show more